Dr. Venkatesan most recently served as Chairman, President, and CEO of Angion Biomedica until its merger with Elicio Therapeutics in 2023. He currently serves as a Board Director at Elicio ...

The undersigned organizations write to express our support for the use of the Congressional Review Act (CRA) to overturn the Federal Trade Commission's (FTC) recent premerger notification rules ...

Centage, a fintech firm based downtown, has appointed Paul Lynch as its new chief executive officer. The company is owned by ...

Stewart’s Shops signed an agreement in September to buy the assets of St. Albans, Vermont-based Jolley Associates, including 45 Jolley convenience stores—38 in Vermont, five in New York and two in New ...

CVS appears uniquely positioned to improve health outcomes, and we appreciate management's focus on better leveraging its assets through digital and other means to bring a more consumer-centric ...

Andrew Garelick joined Munger, Tolles & Olson as a partner in its corporate practice in Los Angeles, the firm announced ...

Tenet Healthcare Corporation (NYSE:THC) reported its fourth-quarter 2024 earnings, revealing a mixed performance that saw ...

A family-owned printing company that provided marketing and other display graphics for nearly 50 years has sold to another ...

In the complex world of business transactions, particularly mergers and acquisitions (M&A), purchase price adjustments are a critical concept ...

Spirit Airlines on Tuesday rejected Frontier Group’s acquisition offer, worth about $2.16 billion, saying the bid from its fellow ultra-low-cost carrier was less beneficial to shareholders than its ...

Spirit Airlines rejected Frontier Group's acquisition offer worth about $2.16 billion, marking the latest failed deal in the ...

SignatureFD wants to stay independent yet be competitive with investor-backed firms writing big checks, its CEO says.